SCGB3A2 and cancer: Our previous study and the present work suggest that a very small amount of LPS, present in the body (~0.05 ng/ml in serum32), is sufficient to interact with SCGB3A2 when administered, and activate pyroptosis of some cancer cells both in humans and mice.